Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-06
1995-08-01
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549398, A61K 3135, C07D31158
Patent
active
054380740
ABSTRACT:
Certain 3-(phenyl, chroman-2-yl, benzofuran-5-yl or benzoxazol-5-yl)-2-(hydroxy or mercapto)propionic acid derivatives and analogs are useful as hypoglycemic and hypocholesterolemic agents.
REFERENCES:
patent: 4025637 (1977-05-01), Dunwell
patent: 4340605 (1982-07-01), Kawamatsu
patent: 4703052 (1987-10-01), Eggler
patent: 4725610 (1988-02-01), Meguro
patent: 4753956 (1988-06-01), Schnur
patent: 4775687 (1988-10-01), Meguro
patent: 4826990 (1989-05-01), Musser
patent: 4897393 (1990-01-01), Iijima
patent: 5037842 (1991-08-01), Goldstein
patent: 5158964 (1992-10-01), Arrowsmith
Seebach et al., Angevandte Chemie, 96(7), 1984, 498.
Benson Gregg C.
Chan Nicky
Pfizer Inc.
Richardson Peter C.
Ronau Robert T.
LandOfFree
3-aryl-2-hydroxypropionic acid derivatives and analogs as hypogl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypogl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypogl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-734025